logo-loader

Oncimmune Holdings' win contracts with Roche and Cedars-Sinai Medical Center for COVID-19 research

Published: 14:56 06 Apr 2021 BST

Oncimmune Holdings PLC's (LON:ONC) Dr. Adam M Hill talks to Proactive London's Katie Pilbeam after landing two substantial new contracts with drug giant Roche Pharmaceuticals and the world-famous Cedars-Sinai Medical Center.

The agreement is for an infectious disease panel that helps predict the severity of Coronavirus (COVID-19) along with the potential effectiveness of vaccines and other drugs used to treat it.

The company also recently raised £9m through a placing which Hill is 'delighted' by and which will be used to ramp up their operations and strengthen the pipeline of productivity.

Oncimmune's strategic pivot aims for robust growth in 2024

Oncimmune Holdings PLC (AIM:ONC) CEO Martin Gouldstone joins Proactive's Stephen Gunnion with highlights of the company's 2023 performance, which included its strategic decision to focus on its ImmunoINSIGHTS platform. A significant development was the sale of its early lung cancer detection...

3 weeks, 1 day ago